SecBot SecBot
PRESS-RELEASE ·Filed Jul 16, 2026

COSM

Cosmos Health Inc.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago WireGlobeNewswire
Press release · Buyback
Actionable Insight • Neutral

The buyback pace is modest relative to the $5M authorization. Monitor for acceleration or completion as a signal of management conviction. No earnings or guidance data — the stock's micro-cap profile means price action may be driven by liquidity rather than fundamentals.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
COSM ▲ +19.67% at T+60d
NEUTRAL call +19.67% · α vs SPY +15.96% · entry $0.2807 → $0.3359
Entry = T+0 close
Jul 16, 2026
via day close
T+1d
-16.35%
call -16.35% · α -15.36%
$0.2348
settled 3mo ago
T+5d
-28.82%
call -28.82% · α -27.15%
$0.1998
settled 3mo ago
T+20d
-26.43%
call -26.43% · α -30.05%
$0.2065
settled 3mo ago
T+60d
+19.67%
call +19.67% · α +15.96%
$0.3359
settled 18d ago

Price Chart

Loading chart...

Executive Summary

Cosmos Health announced the repurchase of an additional 250,000 shares at ~$0.2782 each, bringing total buybacks under its $5M program to ~$1.04M (4.84M shares). The program runs through Dec 31, 2026, and management signaled continued repurchases, citing undervaluation. This is a routine capital allocation update with no material financial impact.

Key Facts

  • Repurchased 250,000 shares at ~$0.2782/share in open market
  • Total repurchases now 4,838,000 shares for ~$1.04M under $5M program
  • Program expires December 31, 2026, may be renewed at discretion
  • CEO stated shares trade 'well below' business value, committed to further repurchases

Financial Impact

~$69,550 spent on latest tranche; total program utilization ~21% ($1.04M of $5M)

share countcash

Risk Factors

  • Buyback program may not be fully utilized; pace depends on market conditions
  • Micro-cap stock with low liquidity — price impact of repurchases may be amplified
  • No financial results or guidance provided in this release

Market Snapshot

Exchange
Nasdaq
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3328729
33 reports for COSM
Performance horizon
50% Hit rate @ T+20 3 of 6 directional calls Went positive at some point 7 of 8 best @ T+60▲ +66.26%Jul 20, 2026
Filters
Rows
Reports for COSM — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
8-K
BULLISH ★ 6/10
$0.2530awaiting T+20—$0.2320 (−8.30%)
Oct 16, 2026
10d ago
SC 13G/A
NEUTRAL ★ 3/10
$0.3250awaiting T+20—$0.2320 (−28.62%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$0.3496awaiting T+20—$0.2320 (−33.64%)
Sep 3, 2026
7w ago
Press Release
BEARISH ★ 6/10
$0.2660 $0.4300▼ −61.65%▼ −62.77%$0.2320 (+12.78%)
Aug 19, 2026
9w ago
Press Release
BEARISH ★ 6/10
$0.1930awaiting T+20—$0.2320 (−20.21%)
Jul 20, 2026
14w ago
Press Release
BULLISH ★ 4/10
$0.2303 $0.2050▼ −10.99%▼ −15.11%$0.2320 (+0.74%)
Jul 17, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2348 $0.2179▼ −7.20%▼ −11.64%$0.2320 (−1.19%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2807 $0.2065▼ −26.43%▼ −30.05%$0.2320 (−17.35%)
Jul 15, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2785 $0.2071▼ −25.64%▼ −27.98%$0.2320 (−16.70%)
Jul 14, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.3071 $0.2198▼ −28.43%▼ −30.92%$0.2320 (−24.45%)
Showing 10 of 33

US Market Status

Market Closed — Opens in 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 16, 2026